SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-21-005544
Filing Date
2021-05-12
Accepted
2021-05-12 16:43:31
Documents
1
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 GOODMAN - CHANGES IN BENEFICIAL OWNERSHIP ownership.html 4  
1 GOODMAN - CHANGES IN BENEFICIAL OWNERSHIP ownership.xml 4 3946
  Complete submission text file 0001387131-21-005544.txt   5457
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP. 509 MADISON AVE NEW YORK NY 10022
Business Address
Goodman Daniel Wintner (Reporting) CIK: 0001775914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 21915728